Ledger.Open graph →
SEC Form D · Amendment · filed May 29, 2019

Cure Pharmaceutical Holding Corp

Offering
$19.0M
Sold
$19.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Oxnard, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Jessica Rousset · Oxnard, CAExecAlan Einstein · Oxnard, CADirectorWilliam Yuan · Oxnard, CADirectorMark Udell · Oxnard, CAExecRobert Davidson · Oxnard, CAExec · DirectorCharles Berman · Oxnard, CADirectorAlex Katz · Oxnard, CAExecLoren Straub · Peachtree Corners, GAExec · DirectorAnthony C. Natale · New York, NYDirectorWilliam Brady · Somerville, MADirectorPatrick Hutchines · Luxembourg, LuxembourgExecGreenoaks Capital Ms Management LLC Aparo Expressway Ii Series · SAN FRANCISCO, CAExecKeith M. Rosenbloom · New York, NYExecJohn Blount · Peachtree Corners, GADirectorJack Barry · Durham, NCExecCelia Jairala · SAN ANTONIO, TXDirectorJonathan Hudacko · OAKLAND, CADirectorSteven Lockshin · OAKLAND, CAExec · DirectorCatherine J. Duffy · Pembroke, BermudaDirectorKathryn Thurston · New York, NYExecVladimir Krin · NEW YORK, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗